Crospon Recieves FDA Clearance for Endoflip with Flip Topography Module
Crospon has received FDA marketing clearance for its Endoflip system with Flip topography module.
The device allows clinicians to assess patient motility disorders during endoscopy.
The Endoflip 2.0 provides imaging software that displays real-time esophageal contractility patterns on a 24” touch-screen.
The patented technology enables gastroenterologists to look for conditions such as achalasia, GEJ outflow obstruction and other major or minor disorders of peristalsis during endoscopy.
Shipments of Endoflip 2.0 systems will begin in June 2017. — Cynthia Jessup